Why CorMedix Therapeutics?

If you are interested in joining an entrepreneurial team, focused on bringing life-saving therapies to market for critical unmet medical needs, consider applying for a role at CorMedix Therapeutics.  The culture at CorMedix Therapeutics is patient-centered where we feel a sense of urgency to solve some of the most pressing issues in hospital-based healthcare.

CorMedix Therapeutics’s greatest asset is our people. We have a deeply experienced team and continue to bring on some of the brightest talent that can problem solve and execute with high-precision. We are passionate about the work we do and how we do it. We believe in building highly engaged teams that exude integrity, open communication, and innovation. We believe in fostering each employee to reach their highest potential by offering an inclusive environment, opportunities to challenge yourself and grow, and a community of purpose.  We expect that everyone here brings their best selves to work and together, our singular efforts culminate into profound and meaningful breakthroughs.

Company Description:

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. CorMedix is commercializing DefenCath® (taurolidine and heparin) for the prevention of catheter-related bloodstream infections in adult patients undergoing hemodialysis via a central venous catheter. Following its August 2025 acquisition of Melinta Therapeutics LLC, CorMedix is also commercializing a portfolio of anti-infective products, including MINOCIN® (minocycline), REZZAYO® (rezafungin), VABOMERE® (meropenem and vaborbactam), ORBACTIV™ (oritavancin), BAXDELA® (delafloxacin), and KIMYRSA® (oritavancin), as well as TOPROL-XL® (metoprolol succinate).

CorMedix has ongoing clinical studies for DefenCath in Total Parenteral Nutrition and Pediatric patient populations and also intends to develop DefenCath as a catheter lock solution for use in other patient populations.  REZZAYO is currently approved for the treatment of candidemia and invasive candidiasis in adults, with an ongoing Phase III study for the prophylaxis of IFD in adult patients undergoing allogeneic BMT. Topline results of the Phase III study for REZZAYO are expected in Q2 2026. For more information visit: www.cormedix.com or www.melinta.com.

POSITION:

The National Field Trainer role is a developmental, rotational position (18 months) designed for Key Account Managers (KAMs) or Senior Key Account Managers who have demonstrated excellence in multiple areas including sales, leadership, clinical aptitude, and CorMedix Therapeutics’ Essential Behaviors.  Success will require one to deliver high impact training and coaching/mentoring to KAMs as well as achieving individual territory goals. 

 

Periodic evaluations by the Sr. Director of Commercial Training and Leadership Development and the KAM’s RSD will be conducted to ensure the NFT is meeting expectations of the rotational NFT position as well as the individual territory.  National Field Trainers will be eligible for a performance bonus based on qualitative and quantitative measures.

 

PRIMARY RESPONSIBILITIES:

The primary responsibilities of the National Field Trainer will be to 1) conduct field rides with both new and tenured KAMs, focusing on speed to impact and competency elevation; and 2) deliver training across all CorMedix Therapeutics’  promoted brands in a variety of settings and venues. The responsibilities of this position will be coordinated with, and will have a dotted line reporting structure with, the Sr. Director of Commercial Training & Leadership Development. Product knowledge, presentation/facilitation skills, selling skills, and company culture will all be important focal areas to facilitate performance above industry standards.  This will be a hybrid position, complimenting individual territory sales responsibility. Specific responsibilities will include, but not limited to:

 

  • Assist in developing and conducting initial sales training, field sales training programs/workshops and POA/sales meeting training workshops
  • Be responsible and accountable for a training project, program, or workshop from start to finish, as directed and coached by the Sr. Director of Commercial Training
  • Assist in developing and conducting virtual & advanced training classes.  These can be selling skill focused or product specific
  • Coach and counsel during field visits with representatives.
  • Assess assigned regions for trends that are impacting business and make recommendations for potential training opportunities
  • Coordination with respective RSDs/sale leaders pre-ride along to determine areas of focus during field rides.  Post-ride includes providing verbal and written feedback to RSDs regarding demonstration of focus areas and developmental plans of action on a KAM-by-KAM basis.

 

SKILLS & REQUIREMENTS:

  • Demonstration of proven track record of success as Key Account Manager or Senior Key Account Manager
  • Demonstration of CorMedix Therapeutics’ Essential Behaviors
  • Demonstrated leadership skills
  • Excellent presentation and facilitation skills
  • Excellent interpersonal skills
  • Strong verbal and written communication skills
  • Strong organizational and time management skills
  • Ability to travel >20% of time for the term of the rotation. The expectation being approximately 1 day/week with 4 days in the field in your current KAM role.

 

QUALIFICATIONS:

  • A well-rounded professional with 1 plus years’ experience with CorMedix Therapeutics.
  • Candidate must have achieved and maintain throughout the rotation period a national CEO Club ranking in the top 50% for 2 of 4 of the previous rolling quarters.
  • Strong leadership skills, high energy, and a passionate champion for the business with an ability to quickly establish credibility throughout the organization.
  • Demonstrated ability to prioritize, plan and execute multiple short- and long-term projects, while meeting all deadlines.
  • Strong ability to identify/anticipate opportunities, challenges, and roadblocks, while maintaining a solutions-focused approach and develops plans accordingly.
  • High level of IT office proficiency required, especially in Excel, PowerPoint, and Word, Veeva/Salesforce, Docebo.
  • Ability to collaborate across multiple internal and external functional groups.
  • Candidate must in good performance and compliance standing with the organization
  • RSD recommendation.
  • NFT Term: January 2026 – June 2027

 

EXEMPT/NON EXEMPT: EXEMPT

EEO Statement: 

CorMedix is an equal opportunity employer. The Company is committed to providing a safe, respectful, and professional work environment that is free from all forms of unlawful discrimination, harassment (including sexual harassment), and retaliation, and complies with all applicable laws prohibiting such conduct. CorMedix does not discriminate against any individual on the basis of race, religion, color, national origin, ancestry, sex, marital/civil union/domestic partner status, family or parental status, sexual orientation, age, disability, or any other status protected under applicable federal, state, or local law.